Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This entry most plausibly refers to a **topical combination product** containing isopropyl alcohol, povidone-iodine, and dexamethasone sodium. In such a formulation, isopropyl alcohol functions as a broad antiseptic/disinfectant, povidone-iodine serves as an iodophor that releases free iodine with broad antimicrobial activity, and dexamethasone sodium provides corticosteroid anti-inflammatory effects via glucocorticoid receptor activation. However, the source text supplied is clearly about **systemic dexamethasone sodium phosphate injection indications** and does not verify this exact three-ingredient combination product, so the precise marketed identity, sponsor, dosage form, and development status of this exact combination remain unconfirmed from the provided evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isopropyl alcohol + povidone-iodine + dexamethasone sodium.